SAN DIEGO--(BUSINESS WIRE)--May 10, 2005--Inovio Biomedical Corporation (AMEX:INO) today reported financial results for the quarter ended March 31, 2005. Total revenue for the quarter ended March 31, 2005, was $961,921, as compared to $69,385 for the same period in 2004. Revenue consisted of license fees, milestone payments, and amounts received from collaborative research and development arrangements and grants.
